OAKResearch

Home

Data

Cryptos
TradFi
All TradFiHeatmapCompare
Projects
Hyperliquid
OAK Index
Yields
Portfolios

Research

See All

Feed

News
Alpha Feed
Daily Recap
Monitoring

About

Store

Block Note

Services

Our Team

Authors

Brand Kit

Affiliates

Twitter

Telegram

Discord

Instagram

Tiktok

Youtube

Legal

  1. Home
  3. TradFi
  5. Ticker
  7. LLY
  9. Vs
  11. V

Eli Lilly and Company (LLY) vs Visa Inc. (V)

See how Eli Lilly and Company and Visa Inc. differ across market data and performance, so you can decide which asset best fits your strategy.

$1,179.11
NYSE
Eli Lilly & Co. is a pharmaceutical company focused on neuroscience, cardiometabolic disease, oncology, and immunology. Its leading products include Verzenio and Jaypirca in cancer treatment; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin in cardiometabolic care; and Taltz and Olumiant in immunology.
View Full Page
$358.56
NYSE
Visa Inc. is the world’s largest payment processor. In fiscal 2025, the company handled nearly $17 trillion in total payment volume. Visa operates in more than 200 countries and territories and processes transactions in over 160 currencies. Its network is capable of handling more than 65,000 transactions per second.
View Full Page

Key Metrics Comparison

Eli Lilly and CompanyLLY
Market Cap
$1.051T
Price
$1,179.11
24h Change
+0.85%
24h Volume
$2.16M
Employees
50,000
Shares Outstanding
944,818,881
Visa Inc.V
Market Cap
$681.889B
Price
$358.56
24h Change
-1.80%
24h Volume
$7.4M
Employees
34,100
Shares Outstanding
1,659,709,932

Category Performance

Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.

Market Share

Share of combined market cap

Market Share
LLY
60.7%
V
39.3%

Volume Share

Share of combined 24h volume

Volume Share
LLY
22.6%
V
77.4%

24h Performance

Price change over last 24 hours

24h Performance
LLY
0.85%
V
-1.80%
Price Comparison
Eli Lilly and Company
Visa Inc.